b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29380385</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>08</Month>\n            <Day>30</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>12</Month>\n            <Day>10</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">2042-7158</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>70</Volume>\n                    <Issue>4</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>Apr</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>The Journal of pharmacy and pharmacology</Title>\n                <ISOAbbreviation>J. Pharm. Pharmacol.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Role of l-arginine/SNAP/NO/cGMP/K<sub>ATP</sub> channel signalling pathway in antinociceptive effect of \xce\xb1-terpineol in mice.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>507-515</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1111/jphp.12864</ELocationID>\n            <Abstract>\n                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The main purpose of this study was to assess the role of l-arginine/SNAP/NO/cGMP/K<sub>ATP</sub> channel pathway in analgesic effects of \xce\xb1-terpineol in mice.</AbstractText>\n                <AbstractText Label="METHODS" NlmCategory="METHODS">Male NMRI mice were pretreated intraperitoneally with NO precursor (l-arginine, 100\xc2\xa0mg/kg), NO synthase inhibitor (l-NAME, 30\xc2\xa0mg/kg), NO donor (SNAP, 1\xc2\xa0mg/kg), guanylyl cyclase inhibitor (methylene blue, 20\xc2\xa0mg/kg), PDE inhibitor (sildenafil, 0.5\xc2\xa0mg/kg), K<sub>ATP</sub> channel blocker (glibenclamide, 10\xc2\xa0mg/kg) and naloxone (2\xc2\xa0mg/kg) 20\xc2\xa0min before the administration of \xce\xb1-terpineol. The formalin test was performed 20\xc2\xa0min after the administration of \xce\xb1-terpineol, and nociceptive responses of mice were recorded during 30\xc2\xa0min.</AbstractText>\n                <AbstractText Label="KEY FINDINGS" NlmCategory="RESULTS">A significant and dose-dependent antinociception was produced by \xce\xb1-terpineol (40 and 80\xc2\xa0mg/kg) in both the phases of formalin test. The antinociceptive effect of \xce\xb1-terpineol was significantly potentiated by l-arginine in the second phase while significantly antagonized by l-NAME in both phases of formalin test. Also, SNAP and sildenafil non-significantly enhanced-while methylene blue significantly diminished-the antinociceptive effect of \xce\xb1-terpineol in both phases of formalin test. Glibenclamide significantly reversed the \xce\xb1-terpineol-induced antinociception, indicating the involvement of K<sub>ATP</sub> channels in antinociceptive effect of \xce\xb1-terpineol.</AbstractText>\n                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These results indicate that the antinociceptive effect of \xce\xb1-terpineol is mediated through l-arginine/SNAP/NO/cGMP/K<sub>ATP</sub> channel pathway.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2018 Royal Pharmaceutical Society.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Safaripour</LastName>\n                    <ForeName>Sara</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Nemati</LastName>\n                    <ForeName>Yasaman</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Parvardeh</LastName>\n                    <ForeName>Siavash</ForeName>\n                    <Initials>S</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5001-4633</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ghafghazi</LastName>\n                    <ForeName>Shiva</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Fouladzadeh</LastName>\n                    <ForeName>Anahita</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Moghimi</LastName>\n                    <ForeName>Mahsa</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>01</Month>\n                <Day>30</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>J Pharm Pharmacol</MedlineTA>\n            <NlmUniqueID>0376363</NlmUniqueID>\n            <ISSNLinking>0022-3573</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000700">Analgesics</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000081005">Cyclohexane Monoterpenes</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D053138">Cyclohexenes</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D054086">KATP Channels</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D039821">Monoterpenes</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>21334LVV8W</RegistryNumber>\n                <NameOfSubstance UI="C016775">alpha-terpineol</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>31C4KY9ESH</RegistryNumber>\n                <NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>79032-48-7</RegistryNumber>\n                <NameOfSubstance UI="D026423">S-Nitroso-N-Acetylpenicillamine</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>94ZLA3W45F</RegistryNumber>\n                <NameOfSubstance UI="D001120">Arginine</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>H2D2X058MU</RegistryNumber>\n                <NameOfSubstance UI="D006152">Cyclic GMP</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>V55S2QJN2X</RegistryNumber>\n                <NameOfSubstance UI="D019331">NG-Nitroarginine Methyl Ester</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000700" MajorTopicYN="N">Analgesics</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001120" MajorTopicYN="N">Arginine</DescriptorName>\n                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006152" MajorTopicYN="N">Cyclic GMP</DescriptorName>\n                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000081005" MajorTopicYN="N">Cyclohexane Monoterpenes</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D053138" MajorTopicYN="N">Cyclohexenes</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D054086" MajorTopicYN="N">KATP Channels</DescriptorName>\n                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D039821" MajorTopicYN="N">Monoterpenes</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019331" MajorTopicYN="N">NG-Nitroarginine Methyl Ester</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName>\n                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>\n                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010147" MajorTopicYN="N">Pain Measurement</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>\n                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D026423" MajorTopicYN="N">S-Nitroso-N-Acetylpenicillamine</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">guanylyl cyclase</Keyword>\n            <Keyword MajorTopicYN="N">nitric oxide</Keyword>\n            <Keyword MajorTopicYN="N">pain signalling</Keyword>\n            <Keyword MajorTopicYN="N">potassium channels</Keyword>\n            <Keyword MajorTopicYN="N">terpenoids</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2017</Year>\n                <Month>05</Month>\n                <Day>08</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2017</Year>\n                <Month>11</Month>\n                <Day>22</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>1</Month>\n                <Day>31</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>8</Month>\n                <Day>31</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>1</Month>\n                <Day>31</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29380385</ArticleId>\n            <ArticleId IdType="doi">10.1111/jphp.12864</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'